Skip to main content
Novartis
language-selector-globe
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Andean & CAC | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
Ukraine | українська
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Andean & CAC | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
Ukraine | українська
United Kingdom | English
United States | English
    • About 
      • Novartis in Ireland 
      • Country Leadership Team 
      • Contact 
      Novartis office
      About
    • Patients and Caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Education and Awareness 
      • Patient Resources 
      • Adverse Event Reporting 
      • Novartis Societal Impact 
      Happy family outdoors
      Patients and Caregivers
    • Healthcare Professionals 
      • Healthcare professional country resource 
      • Adverse Event Reporting 
      • Novartis Clinical Trials 
      • Novartis Ireland travel and Expenses Guidance 
      Healthcare professional talking with patient.
      Healthcare Professionals
    • ESG 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
      • Ethics, Risk and Compliance 
      • Environmental Sustainability 
      As a global company, Novartis has a great responsibility and an even greater opportunity to lead the world in creating a positive social change, embracing societal impact as a core business objective.
      ESG
    • News 
      • News Archive 
      • Stories 
      • Contacts 
      Working on a Tablet
      News
    • Careers 
      • Career Search 
      • Working in Novartis Ireland 
      • Learning and Development 
      • Early Talent 
      • How We Work 
      • Well-being 
      • Diversity & Inclusion 
      • Awards and Recognition 
      Careers
      Careers
    • Investors
      • Financial Data 
    • Coronavirus 
      covid 10 grey image_0_0
      Coronavirus
    Home

Stories

Story Navigation
  • All Topics
  • Education & Awareness
  • Corporate
  • People and Culture
icon
  • be-brain-aware-meeting
    Education Awareness
    Mar 17, 2022

    "Be Brain Aware" public meeting for Brain Awareness Week

    Education Awareness
  • Symtrac launch
    Education Awareness
    Mar 17, 2022

    First of its kind disease tracking and management resource launched for people with MS – SymTrac

    Education Awareness
  • Almost 400 people received a free AMD eye test
    Education Awareness
    Mar 17, 2022

    Almost 400 people received a free AMD eye test from the Novartis mobile testing unit during AMD Awareness

    Education Awareness
  • Creating greater awareness of COPD and medicines at Novartis
    Education Awareness
    Mar 17, 2022

    Creating greater awareness of COPD and medicines at Novartis Ringaskiddy

    Education Awareness
  • AMD Awareness Week campaign
    Education Awareness
    Mar 17, 2022

    Awareness week: 10% people Tested During AMD Week Referred to an Eye Specialist

    Education Awareness

Pagination

  • ‹ Previous page
  • 1
  • …
  • 4
  • › Next page

Novartis Ireland

Navigate Novartis
  • Patients and Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • News Archive
  • Stories
Other Novartis Websites
  • Healthcare Professional Resources
  • Global site
Footer Bottom
© 2025 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
Site intended for audiences in Ireland IE417033 March 24